UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000006823
Receipt No. R000008068
Scientific Title Phase II study of S-1 plus irinotecan combined with biweekly cetuximab as 2nd-line chemotherapy in patients with wild type KRAS unresectable colorectal cancer, who had previously received oxaliplatin-based chemoterapy without CV port. (FUTURE 1103 STUDY)
Date of disclosure of the study information 2011/12/03
Last modified on 2011/12/03 12:02:44

No. Disposal Last modified on Item of update
1 Insert 2011/12/03 12:03:46


Contact us.